| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Cura Technologies Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Non-Current Assets |
|
|
|
Property, Plant & Equipment |
177.47 |
- |
|
Goodwill |
1,585.27 |
- |
|
Other Intangible assets |
0.13 |
- |
|
Total Non-Current Assets |
1,762.87 |
- |
|
Cash & Cash Equivalents |
10.19 |
77.36 |
|
Loans & Advances |
107.07 |
- |
|
Other Current Assets |
6.62 |
- |
|
Total Current Assets |
123.88 |
77.36 |
|
Total Assets |
1,886.76 |
77.36 |
|
Equity |
|
|
|
Equity Share Capital |
915.00 |
195.00 |
|
Other Equity |
(203.16) |
-136.87 |
|
Total Equity |
711.84 |
58.13 |
|
Non-Current Liabilities |
|
|
|
Borrowings |
446.27 |
19.23 |
|
Total Non-Current Liabilities |
446.27 |
19.23 |
|
Current Liabilities |
|
|
|
Trade Payables |
|
- |
|
Other Current Liabilities |
728.65 |
- |
|
Provisions |
|
- |
|
Total Current Liabilities |
728.65 |
- |
|
Total Equity & Liabilities |
1,886.75 |
77.36 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Revenue from Operations |
- |
- |
|
Other Income |
- |
- |
|
Total Income |
- |
- |
|
Expenses |
|
|
|
Employee benefits expenses |
4.83 |
|
|
Finance costs |
0.01 |
|
|
Depreciation and Amortization Expenses |
0.06 |
- |
|
Other Expenses |
61.40 |
(94.08) |
|
Total Expenses |
66.29 |
(94.08) |
|
Profit/(Loss) for the period |
(66.29) |
(94.08) |
|
Total Comprehensive Income for the
period |
(66.29) |
(94.08) |
|
Earning per Equity Share (For Continuing & Discontinued
Operations) |
|
|
|
Basic |
(2.320) |
(4.825) |
|
Diluted |
(2.320) |
(4.825) |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Cash flow from operating activities |
|
|
|
Net Loss/(Profit) before extraordinary items and tax |
(66.29) |
(94.08) |
|
Adjustment for: |
|
|
|
Depreciation and amortisation of non-current assets |
0.06 |
- |
|
Operating profit/(loss) before working capital changes |
(66.23) |
(94.08) |
|
Changes in working capital |
|
|
|
Increase/Decrease Trade in Other current assets |
(6.62) |
- |
|
Increase/Decrease in loans & Advances |
(107.07) |
- |
|
Increase/Decrease in Other Current Liabilities |
728.65 |
(5.39) |
|
Net cash flow from / (used in) operating activities (A) |
548.72 |
(99.47) |
|
Cash flow from investing activities |
|
|
|
Purchase of Property, Plant & Equipment & goodwill |
(1,762.92) |
- |
|
Net cash flow from / (used in) investing activities (B) |
(1,762.92) |
- |
|
Cash flow from financing activities |
|
|
|
Increase/(Decrease) in share capital |
720.00 |
156.67 |
|
Share Application money |
(19.23) |
0.53 |
|
Unsecured Loan Taken |
446.27 |
- |
|
Net cash flow from / (used in) financing activities (C) |
1,147.04 |
157.20 |
|
Net increase/(decrease) in Cash and cash equivalents |
(67.17 |
57.73 |
|
Cash and cash equivalents at the beginning of the year |
77.36 |
19.64 |
|
Cash and cash equivalents at the end of the year |
10.19 |
77.37 |
The company generated positive operating cash flow of ₹548.72 lakh in FY2025 compared to negative ₹99.47 lakh in FY2024.
Key observations:
* The company reported an accounting loss before tax of ₹66.29 lakh, indicating that profitability has not yet been achieved.
* However, strong working-capital movements significantly improved operating cash:
Increase in loans & advances and other current assets led to cash outflows.
* The positive operating cash despite losses suggests:
operational cash stability emerging, but still dependent on liability buildup.
Interpretation:
Operating cash flow improvement is encouraging, but it is not driven by core profitability; rather, it is largely supported by working-capital changes.
The company recorded a significant outflow of ₹1,762.92 lakh in FY2025.
* Major investment in Property, Plant & Equipment and goodwill
* Indicates expansion, acquisition, or infrastructure build-up.
Interpretation:
This reflects an aggressive investment phase, suggesting long-term growth plans, capacity expansion, or technology acquisition. However, such heavy investment increases funding dependence and execution risk.
Financing cash inflow increased substantially to ₹1,147.04 lakh in FY2025 from ₹157.20 lakh in FY2024.
Sources of funds:
* Equity infusion (share capital): ₹720 lakh
* Unsecured loans: ₹446.27 lakh
* Reduction in share application money.
Interpretation:
The company is funding its expansion primarily through equity and borrowings, indicating:
external capital dependence
early-stage or growth-stage financing pattern.